🔗 Share this article

Chancellor Reeves has revealed she is preparing "targeted steps to tackle household expense challenges" in next month's financial statement.

During an interview with the BBC, she emphasized that curbing inflation is a collective duty of both the administration and the central bank.

The United Kingdom's price growth is projected to be the highest among the G7 developed nations this year and the following year.

Potential Utility Bill Interventions

It is understood the administration could intervene to bring down utility costs, for instance by slashing the current 5% rate of VAT charged on energy supplies.

Another possibility is to cut some of the regulatory levies presently included in household expenses.

Budgetary Constraints and Analyst Predictions

The administration will receive the next report from the official forecaster, the OBR, on Monday, which will show how much scope there is for these actions.

The expectation from most analysts is that the Chancellor will have to declare tax rises or expenditure reductions in order to meet her self-imposed debt limits.

Previously on the same day, estimates indicated there was a £22bn deficit for the chancellor to resolve, which is at the lower end of forecasts.

"It is a shared task between the central bank and the government to bear down further on some of the sources of price increases," the Chancellor stated to the BBC in the US capital, at the conferences of the IMF and World Bank.

Tax Pledges and Global Concerns

While much of the attention has been on expected tax rises, the chancellor said the most recent information from the OBR had not changed her commitment to manifesto promises not to raise rates on income tax, VAT or social security contributions.

She attributed an "unpredictable global environment" with growing geopolitical and commercial tensions for the Budget tax moves, likely to be targeted on those "wealthiest."

International Economic Tensions

Addressing worries about the United Kingdom's trade ties with the Asian nation she said: "The UK's security interests invariably take priority."

Recent announcement by Chinese authorities to tighten export controls on rare earths and other materials that are crucial for high-technology manufacturing led US President Donald Trump to threaten an further 100% tariff on goods from the Asian country, raising the risk of an full-scale commercial conflict between the two largest economies.

The American finance chief called China's move "commercial pressure" and "a global supply chain control attempt."

Asked about considering the US offer to participate in its dispute with the Asian nation, the Chancellor said she was "very concerned" by Chinese actions and called on the Chinese government "not to put up barriers and limit trade."

She said the move was "bad for the global economy and generates further headwinds."

"It is my opinion there are sectors where we must challenge China, but there are also valuable chances to sell into Chinese markets, including banking sector and other areas of the economy. We've got to maintain that balance appropriate."

The Treasury chief also stated she was collaborating with G7 counterparts "on our own essential resources plan, so that we are less reliant."

NHS Drug Costs and Funding

The Chancellor also recognized that the price the NHS pays for medicines could increase as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in return for reduced taxes and investment.

A number of the biggest global drug companies have said lately that they are either delaying or abandoning projects in the UK, with several attributing the insufficient payments they are getting.

Recently, the Science Minister said the price the health service spends on medicines would need to rise to stop businesses and pharmaceutical investment leaving the United Kingdom.

The Chancellor told the BBC: "We have seen as a result of the cost structure, that drug testing, innovative medicines have not been provided in the UK in the extent that they are in other EU nations."

"The objective is to make sure that patients getting care from the NHS are able to obtain the top critical medicines in the globe. And so we are reviewing these issues, and... looking to obtain more funding into Britain."